Stay updated on Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Fallopian tube cancer to the conditions and updated the document revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check32 days agoChange DetectedPrimary peritoneal carcinoma was added to the study's conditions. The page revision indicates v3.4.1.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now shows a revision tag of v3.3.4, replacing the previous v3.3.3 tag. This is a minor maintenance update and does not alter study details or navigation.SummaryDifference0.0%

- Check75 days agoChange DetectedThe Locations section has been revised to include many new study sites across the US and internationally (Australia, Canada, Europe). Several previously listed locations were removed.SummaryDifference2%

- Check104 days agoChange DetectedA note clarifying that publications are automatically filled from PubMed was added, and the page now shows Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.